ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1472	National Cancer Institute	Html	en	Endometrial Cancer Treatment (PDQ®)–Health Professional Version	Endometrial cancer is usually diagnosed at an early stage and can be treated with surgery. Learn about the symptoms, diagnosis, prognosis, staging, and treatment for early- and advanced-stage endometrial cancer in this expert-reviewed summary.	Obstet Gynecol 0.477047 papillary serous carcinoma 0.485706 endometrial cancer staging 0.480093 uterine cancer 0.371407 positive peritoneal cytology 0.407977 endometrial carcinoma 0.678904 normal endometrial 0.464798 endometrial cancer stage 0.512175 Int J Radiat 0.414383 Radiat Oncol Biol 0.512336 surgical staging 0.377398 oncology group study 0.48351 prognostic significance 0.39336 Natl Cancer Inst 0.399994 cell endometrial cancer 0.498772 Gynecologic Oncology Group 0.519757 endometrial hyperplasia 0.463477 Gynecol Oncol 0.817345 radiation therapy 0.404405 endometrial cancer 0.939144 early-stage endometrial cancer 0.512325 peritoneal cytology 0.432244 stage-1 endometrial carcinoma 0.468917 endometrial lining 0.46346 et al. 0.506597	clear cell endometrial 0.473365 progesterone receptor content 0.393655 stage endometrial cancer 0.540703 stage uterine papillary 0.382976 serous endometrial cancer 0.492942 type endometrial cancer 0.479957 endometrial tissue 0.462216 papillary serous cancer 0.3874 endometrial cancer patients 0.547475 early stage endometrial 0.515429 stage IIB patients 0.37429 risk endometrial adenocarcinoma 0.459895 Endometrial Cancer Study 0.48075 surgical-pathological risk factors 0.372575 endometrial canal 0.462243 comprehensive surgical staging 0.375341 Abstract 0.581453 progesterone receptor levels 0.46561 Clin Oncol 0.418943 surgical stage 0.412306 Oncol Biol Phys 0.518638 uterine papillary 0.386955 clinical stage 0.37895 vaginal brachytherapy 0.371898	CLICK HERE
1695	National Cancer Institute	Html	en	High-Dose Vitamin C (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of high-dose vitamin C as a treatment for people with cancer.	ascorbic acid cause 0.642882 prostate cancer cell 0.630423 /IV ovarian cancer 0.57305 oral ascorbic acid 0.649173 vitamin C therapy 0.612109 vitamin C. 0.610223 cancer information summary 0.591614 weekly ascorbate infusions 0.607343 multiple myeloma patients 0.578578 ovarian cancer 0.574477 cancer patients 0.68661 vitamin 0.72459 high-dose vitamin 0.665873 oral vitamin 0.706163 significant adverse events 0.605455 high-dose IV ascorbate 0.593412 colon cancer cells 0.587994 ascorbic acid treatment 0.848969 metastatic colorectal cancer 0.572155 vitamin C supplements 0.616683 ascorbic acid 0.99701 study 0.585466 current clinical trials 0.571291 case series 0.594589 tumor volume 0.583085	pancreatic cancer patients 0.683645 dehydroascorbic acid 0.640204 terminal cancer patients 0.626123 cancer cells 0.588032 bortezomib growth inhibition 0.576885 high-dose ascorbic acid 0.717915 studies 0.596394 pharmacological ascorbate 0.581055 breast cancer cells. 0.579255 decrease cell proliferation 0.57116 ascorbic acid synthesis 0.660705 cancer cell lines. 0.642672 L-ascorbic acid 0.574809 intracellular ascorbic acid 0.648545 high-dose IV vitamin 0.658734 healthy volunteers 0.583492 inhibitory effect 0.590166 cancer cell death 0.591483 oxidized form 0.602818 cancer cell xenografts 0.58194 ascorbic acid. 0.583971 ascorbate 0.663468 tumor inhibitory effect 0.580256 cancer 0.692622	CLICK HERE
1751	National Cancer Institute	Html	en	Hospice Care	A fact sheet about hospice care, including insurance coverage.	palliative care share 0.4463 home health 0.436046 hospice programs 0.663338 hospice team 0.740949 specific care decisions 0.42786 hospice doctor 0.624846 spiritual support 0.408056 public health departments 0.391127 American Cancer Society 0.455655 hospice services 0.722561 home health aides 0.405139 state Medicaid office 0.402126 nursing care 0.391635 hospice medical director 0.768439 Hospice Association 0.649826 cancer care 0.409838 hospital business office 0.388593 life expectancy 0.408587 hospice team member 0.685192 special in-patient facilities 0.500987 Medicare website 0.415518 specific state locations 0.392604 government health insurance 0.402081 sheet Palliative Care 0.444628 state social services 0.40519	nursing homes 0.407681 end-of-life care 0.424373 health aide services 0.410795 hospice organizations 0.592662 Palliative Care Organization 0.507564 private insurance plans 0.399019 Hospice Net 0.623257 palliative care 0.604188 Medicare coverage 0.386456 national hospice 0.673933 regional home health 0.398589 national hospice programs 0.634262 hospice care 0.982488 local state welfare 0.391739 health insurance plans 0.419219 Medicare benefits 0.388255 hospice expenses 0.700651 insurance plans 0.503978 federal-state partnership program 0.389089 Medicare Hospice Benefits 0.695621 Medicare-certified hospice programs 0.660409 Respite Care page 0.429976 social work services 0.407475 free fact sheets 0.38648	CLICK HERE
1841	National Cancer Institute	Html	es	Tratamiento del cáncer de intestino delgado (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de intestino delgado.	Serour F 0.235745 Lippincott Williams 0.238115 Compton CC 0.588526 M)a aReproducción 0.23829 accessed october 0.241973 Definiciones TNM 0.236983 American Cancer Society 0.407525 7th ed 0.585523 Zeh HJ III 0.264951 Zureikat AH 0.235019 Dona G 0.235003 Small bowel tumors 0.287594 Instituto Nacional 0.346133 DeVita VT Jr 0.263261 Malignant tumors 0.234868 Chen CC 0.239394 Eto T 0.235436 Rosenberg SA 0.234255 tumores carcinoides 0.932641 Tsunoda T 0.234397 Lawrence TS 0.234618 malignant neoplasms 0.237309 tumores carcinoides gastrointestinales 0.457635 estadio ii 0.290896 Cancer Facts 0.258856	Ahsan H 0.236233 Birkenfeld S 0.235158 malignant small bowel 0.287742 Am Surg 0.243892 Cancer Staging Manual 0.891975 National Cancer Institute 0.259977 small bowel 0.440838 rara vez 0.23641 Surg Oncol 0.338089 PDQ Tratamiento 0.993362 New York 0.545893 Primary neoplasms 0.238508 9th ed 0.239679 Physician Data Query 0.250873 Hochwald SN 0.233655 Byrd DR 0.571234 Matsuo S 0.234278 Heller MT 0.2353 Primary duodenal 0.236001 Am Coll Surg 0.2682 Tis Carcinoma 0.238384 T)a aReproducción 0.237792 AJCC Cancer Staging 0.895181 Edge SB 0.590374	CLICK HERE
1967	National Cancer Institute	Html	es	Tratamiento del cáncer de pene (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de pene.	siguientes procedimientos 0.765966 siguientes aspectos 0.663436 radiosensibilizadores ayuda 0.608332 estadio ii 0.653561 ganglio linfático centinela 0.99757 rayos x 0.61452 menor cantidad 0.630187 enlace drugs approved 0.616023 ondas sonoras 0.614903 National Cancer Institute 0.60451 siguientes riesgos 0.604706 papiloma virus 0.656514 únicos tratamientos 0.60726	Instituto Nacional 0.609778 Penile Cancer 0.60882 estadio iiia 0.623114 PDQ Tratamiento 0.608893 cuerpo esponjoso 0.725663 presente sección 0.608144 Physician Data Query 0.620917 siguientes sitios 0.675658 siguientes operaciones 0.617884 órgano masculino 0.616691 siguientes pruebas 0.65372 siguientes estadios 0.621615	CLICK HERE
2057	National Cancer Institute	Html	es	Cáncer de hueso	Hoja informativa acerca del diagnóstico y tratamiento de los cánceres que se presentan en los huesos.	Lippincott Williams 0.528921 Pediatric Oncology 0.425852 DeVita VT 0.423199 Grandes avances 0.423263 Fischbach FT 0.422317 tejido óseo 0.925192 rayos x 0.477476 American Cancer Society 0.521554 página web guía 0.432205 7th ed 0.466045 altas dosis 0.425962 enfermedades infantiles congénitas 0.446544 Diagnostic Tests 0.424605 fosfatasa alcalina 0.483649 distintos tipos 0.471502 médico pregunta 0.42954 Pizzo P 0.423691 Estados Unidos 0.422015 survival among children 0.439442 Boice JD 0.42308 Rosenberg SA 0.420738 Fraumeni JF 0.42331 tumor óseo 0.736727 Schottenfeld D 0.42165	States SEER Program 0.439663 importante opción 0.422974 mejores formas 0.420225 pequeña cantidad 0.471903 editors.  cancer 0.434055 gammagrafía ósea 0.428461 O'Sullivan B 0.421908 Malawer MM 0.422909 Curtis RE 0.421362 probables beneficios 0.422945 National Cancer Institute 0.447941 4th ed 0.425929 Ries LAG 0.424185 Ewing Sarcoma Family 0.452617 Hellman S 0.421499 Dunning MB 0.422439 Retrieved March 0.423884 emission tomography 0.426368 enzima llamada 0.426279 cabo estudios 0.429851 Helman LJ 0.424392 Gurney JG 0.42319 Poplack DG 0.422887 Miller RW 0.421236	CLICK HERE
3880	National Cancer Institute	Html	es	Extractos de muérdago (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso de los extractos de muérdago como tratamiento para personas con cáncer.	from mistletoe extract 0.31162 Cancer Res Clin 0.306787 mistletoe extracts 0.396569 album extract isorel 0.309539 Mistletoe extracts standardised 0.30709 viscum album 0.980886 galactoside-specific lectin from 0.335383 thionins from viscum 0.3152 muérdago i 0.308032 treated with viscum 0.312029 Cancer Res 0.31513 isolated from viscum 0.307496 extracto viscum album 0.308065 Viscum album agglutinin-induced 0.308373 with viscum album 0.33586 from viscum album 0.472392 beta-galactoside-specific lectin from 0.310754 Hajto T 0.314595 extract from viscum 0.316835 Viscum album enhancing 0.30854 patients with 0.307472 thionins from european 0.306901 Immunomodulatory Agents from 0.306741 viscum album extract 0.338924 viscum album l 0.601922	Mistletoe lectins as 0.306952 preparation from viscum 0.308802 Complement Ther Med 0.308742 tumor cell 0.31334 Mistletoe extracts standardized 0.30726 Beuth J 0.317637 mistletoe treatment 0.310143 lectin from 0.350339 derived from viscum 0.315008 In vitro effects 0.312037 Schaller G 0.307482 blood mononuclear cells 0.315901 subspecies viscum album 0.308835 lectin from viscum 0.322905 Gabius HJ 0.329931 Viscum album induces 0.316269 ml1 from viscum 0.307567 breast cancer 0.326075 Viscum album species 0.308916 plant lectin 0.306716 mistletoe lectins 0.449053 in vitro 0.456679 Hostanska K 0.309958 fermented extract from 0.30821	CLICK HERE
15643	National Cancer Institute	Html	en	Grants Policies and Process	NIH prior approval is required for the transfer of a grant. Learn more about transferring a cancer research grant from one entity to another.	National Cancer Institute 0.966549		CLICK HERE
16162	National Cancer Institute	Html	en	New Therapies Are Changing the Outlook for Advanced Melanoma	An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.	improved progression-free survival 0.366558 new therapies 0.351845 target BRAF proteins 0.357172 commonly used therapies 0.342946 BRAF inhibitor 0.43187 BRAF mutations 0.802264 Cancer Therapy Evaluation 0.357896 Overall survival results 0.381093 Dr. Schuchter 0.658164 overall survival 0.53856 clinical trials 0.561097 results 0.412771 median progression-free survival 0.364224 clinical trial 0.629151 median overall survival 0.359384 patients 0.941423 recent FDA-approved drugs 0.349384 tumor responses 0.376799 metastatic melanoma 0.378989 chemotherapy drug dacarbazine 0.34213 median survival 0.400006 melanoma specialist 0.389264 large clinical trial 0.469476 MEK inhibitor 0.413513	cancer cells 0.348742 Patient tumor samples 0.353483 skin-related side effects 0.386676 MEK inhibitor cobimetinib 0.40543 clinical trial participants 0.357541 BRAF-MEK inhibitor combination 0.3755 Dr. Streicher 0.487979 tumor cells 0.429743 checkpoint inhibitor 0.371337 small clinical trials 0.342687 drugs 0.41439 progression-free survival 0.707667 MEK inhibitors 0.605005 advanced melanoma 0.87481 PD-1 inhibitor 0.342866 recent clinical trials 0.345485 new treatment options 0.457424 tumors 0.426135 New Melanoma Therapies 0.48664 early-phase clinical trial 0.367414 Moffitt Cancer Center 0.358773 regulatory approval 0.407964 Pennsylvania Abramson Cancer 0.343564 skin cancer melanoma 0.49678	CLICK HERE
16709	National Cancer Institute	Html	es	ALCHEMIST (Estudios sobre la Secuenciación e Identificación de Marcadores para el Mejoramiento de la Terapia Adjuvante para el Cáncer de Pulmón): Preguntas y respuestas	ALCHEMIST comprende tres estudios clínicos integrados de medicina de precisión diseñados para identificar a personas con cáncer de pulmón en estadio inicial cuyos tumores tienen ciertos cambios genéticos poco comunes. También buscan evaluar si los tratamientos con medicamentos que combaten esos cambios moleculares pueden mejorar la supervivencia	Geoffrey Oxnard 0.313105 estudios clínicos alchemist 0.419541 genes egfr 0.537115 tumor carcinoide 0.318935 gen alk 0.998441 estudio alchemist 0.428836 cáncer nsclc 0.336759 Clinical Trials 0.385899 Washington University 0.311286 estudios alchemist hombres 0.406835 Dana-Farber Cancer Institute 0.323728 estadio ib 0.321816 largo plazo 0.311737 Cáncer ECOG-ACRIN 0.357818 Clinical Laboratory Improvement 0.323435 Cancer Enrichment Marker 0.325429 Cancer Genome Analysis 0.324094 Pasi A 0.313281 compañías farmacéuticas socias 0.322405 National Human Genome 0.322496 Instituto Nacional 0.327493	estadio iiia 0.321214 David E 0.311651 Terapia Adjuvante 0.312862 NCI Community Oncology 0.329248 Genoma Humano 0.311302 Ramaswamy Govindan 0.314989 gen egfr 0.724341 alchemist correspondientes 0.435182 Estados Unidos 0.373254 Texas Southwestern Medical 0.321883 cabo estudios 0.336005 principales objetivos 0.311051 Vysis ALK break-apart 0.345879 compañía response genetics 0.320675 estudios alchemist 0.840169 Astellas Pharma US 0.321115 Cancer Genomics 0.314435 Oncología NRG 0.312826 radioterapia posoperatorias 0.315764 Sequencing Trials 0.317534 Institutos Nacionales 0.331134	CLICK HERE